Literature DB >> 17198639

[Cronkhite-Canada syndrome: an acquired, potentially reversible polyposis].

Eva Marín Serrano1, Pablo Guillén Mariscal, José Pérez-Requena, Paloma Rendón Unceta.   

Abstract

Cronkhite-Canada syndrome is an infrequent, nonadenomatous, acquired polyposis that is associated with ectodermic alterations. The etiopathogenesis and optimal therapeutic management are unknown. We present a case of Cronkhite-Canada syndrome in a 58-year-old man who, after combined treatment with corticosteroids, disodium cromoglycate, loratadine, ciprofloxacin, and zinc, showed complete clinical and partial endoscopic remission. The polypoid lesions of Cronkhite-Canada syndrome can be reversed with medical treatment. Consequently, the natural history of the disease can be modified and its prognosis improved.

Entities:  

Mesh:

Year:  2006        PMID: 17198639     DOI: 10.1157/13095196

Source DB:  PubMed          Journal:  Gastroenterol Hepatol        ISSN: 0210-5705            Impact factor:   2.102


  1 in total

1.  The Long-Term Clinical and Endoscopic Outcomes of Cronkhite-Canada Syndrome.

Authors:  Shuang Liu; Yan You; Gechong Ruan; Liangrui Zhou; Dan Chen; Dong Wu; Xuemin Yan; Shengyu Zhang; Weixun Zhou; Ji Li; Jiaming Qian
Journal:  Clin Transl Gastroenterol       Date:  2020-04       Impact factor: 4.396

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.